A meta-analysis of long-term data suggests that both drug-eluting stent percutaneous coronary intervention (DES-PCI) and ...
Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally delivered cell therapy to enhance therapeutic ...
Transcatheter aortic valve replacement (TAVR) with a self-expanding valve still worked out better, at least in terms of ...
On Thursday during a Hotline / Late-Breaking Trials session, Dr. Toru Tanigaki of Gifu Heart Center in Gifu, Japan, will present the one-year results of the PROVISION 1 Study, the first-ever Japanese ...
Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that two abstracts ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. EuroPCR 2014 featured a wide variety of important ...
Paris, France and Munich, Germany, 22 May, 2025 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is presenting data in a ...
1. The "Radial Paradox": Higher Femoral Access Site Complications Offsets Radial Benefits Growing acceptance of radial access during cardiac catheterisation to reduce access site complications may ...
Please provide your email address to receive an email when new articles are posted on . Martin W. Bergmann, MD, presented 3-month outcome data of patients with atrial fibrillation treated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results